685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER, NJ
Amended material disclosure
Other Events
Earnings Release
Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger
Submission of Matters to a Vote of Security Holders
Bringing Life Into Balance July 2026
Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
Annual Report to Security Holders
Q2
FY 2024
Q3
Q1
Effectiveness Notice
Prospectus Filed Pursuant to Rule 425
Prospectus filed pursuant to Rule 424(b)(3)
S-4/A
S-4
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Schedule 13D - Ownership Report
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload